Effect of Amygdalus scoparia kernel (ASK) oil consumption on lipid profile in patients with dyslipidemia

Effect of Amygdalus scoparia kernel (ASK) oil consumption on lipid profile of patients with dyslipidemia referred to Health Heart House affiliated to Shiraz Cardiovascular Research Center.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201411121525N3

Enrollment

110

Registered

2015-03-10

Start date

2014-06-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia. Disorders of Lipoprotein metabolism and other Lipidaemias

Interventions

Intervention 1: Control group : No Intervention. Intervention 2: Intervention group:Use Amygdalus Scoparia Kernel (ASK) Oil Orally 10 cc per Day for 60 Days.

Treatment - Other

Control group : No Intervention

Intervention group:Use Amygdalus Scoparia Kernel (ASK) Oil Orally 10 cc per Day for 60 Days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: age 20-70 year old; Low-density lipoprotein (LDL) 130 -200 or triglyceride 150-400 or High-density lipoprotein (HDL) less 50 in female and less 40 in male; non-use antilipideimic drugs; non history of renal, liver, kidney, heart and thyroid disease; non history of diabetes mellitus; non history of food allergy especially to soya, peanuts and Walnuts; non history of asthma or atopic dermatitis. Exclusion criteria: breastfeeding and pregnancy; oral contraceptive pills consumption; use of antilipideimic drugs; alcohol consumption; hospitalization during study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum Triglyceride. Timepoint: Before and 2 Months After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.;Low-Density Lipoprotein (LDL). Timepoint: Before and 2 Months After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.;High-Density Lipoprotein (HDL). Timepoint: Before and 2 Months After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.;Total Cholesterol. Timepoint: Before and 2 Months After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.	—

Measure

Time frame

Serum Triglyceride. Timepoint: Before and 2 Months After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.;Low-Density Lipoprotein (LDL). Timepoint: Before and 2 Months After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.;High-Density Lipoprotein (HDL). Timepoint: Before and 2 Months After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.;Total Cholesterol. Timepoint: Before and 2 Months After Intervention. Method of measurement: Biochemical Measurements on Blood Sample.

—

Secondary

Measure	Time frame
Weight. Timepoint: Before and 2 Months After Intervention. Method of measurement: Before and 2 Months After Intervention.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Shahamat

Shiraz University of Medical Sciences

shahamatmaryam@gmail.com+98 71 3628 1561

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026